Edward M. MD Kaye - 30 Dec 2024 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Signature
/s/ Jonathan Allan, Attorney-in-Fact
Issuer symbol
STOK
Transactions as of
30 Dec 2024
Net transactions value
+$21,000
Form type
4
Filing time
02 Jan 2025, 16:14:59 UTC
Previous filing
11 Dec 2024
Next filing
06 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STOK Common Stock Options Exercise $21,000 +35,000 +57% $0.6000 96,885 30 Dec 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STOK Employee Stock Option (Right to Buy) Options Exercise $0 -35,000 -5.8% $0.000000 567,801 30 Dec 2024 Common Stock 35,000 $0.6000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option became fully vested as of October 17, 2022.